Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN: A Phase IV Study of Outcome Assessments of Physical Therapy in Subjects in an "On" Versus "End-of-Dose-Off" Motor State
Phase of Trial: Phase IV
Latest Information Update: 14 Feb 2017
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms PERFORM
- Sponsors US WorldMeds
- 09 Feb 2017 Status changed from active, no longer recruiting to discontinued.
- 21 Nov 2016 Status changed from recruiting to active, no longer recruiting.
- 04 Oct 2016 Planned End Date changed from 1 Oct 2016 to 1 Feb 2017.